Autopsy report · NCT01114750
A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)
Cause of deathNo reason given
Life of this trial
- Suspended: paused, and may or may not restart.
- 8 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 1
- Sponsor
- Bows Pharmaceuticals AG
- Sponsor type
- Industry
- Conditions
- Diabetes Mellitus
- Interventions
- Insulin in dextran matrix capsule (and placebo)
- Participants
- 8 (planned, not actual)
- Sites
- 1
- Countries
- Sweden
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.